Human organoids for Risk Group 4 virus research: a new frontier in investigating Nipah virus infection of the central nervous system

Advanced development of medical countermeasures against Risk Group 4 viruses, such as the Nipah virus, historically required testing in mammals under the FDA Animal Rule and translation of data to inform clinical trials in humans. Because the application of human organoids in research on viruses pathogenic for humans is conspecific, it bears the potential to reduce, refine, or replace animal studies where unnecessary. Human cerebral organoids are three-dimensional cell aggregates that resemble the developing human brain functionally and structurally. Brain organoids may be valuable in investigating the replication, neuroinvasion, pathogenesis, virulence, and persistence of neurotropic viruses and provide scientific discernment when developing medical countermeasures destined for the human end-user.

Authors

Institutions

Publication Details

Journal
Journal of Virology
Published
2025-10-29
DOI
https://doi.org/10.1128/jvi.01070-25
Primary Topic
Virology and Viral Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Human organoids for Risk Group 4 virus research: a new frontier in investigating Nipah virus infection of the central nervous system

Amanda M.W. Hischak, Jens H. Kuhn, Lina Widerspick, Shuǐqìng Yú et al.
Journal of Virology
Virology and Viral Diseases
article

Human organoids for Risk Group 4 virus research: a new frontier in investigating Nipah virus infection of the central nervous system

Amanda M.W. Hischak, Jens H. Kuhn, Lina Widerspick, Shuǐqìng Yú, John G. Bernbaum, Daniel B. Woodburn, Ian Crozier, Jillian Geiger, Songelí Menezes Freire, Gabriella Worwa, Julie P. Tran, César Muñoz‐Fontela, Bapi Pahar, Louis Huzella, Gustavo Palacios, Nicole Kleinstreuer, Jeremy J. Bearss
article en

Abstract

Advanced development of medical countermeasures against Risk Group 4 viruses, such as the Nipah virus, historically required testing in mammals under the FDA Animal Rule and translation of data to inform clinical trials in humans. Because the application of human organoids in research on viruses pathogenic for humans is conspecific, it bears the potential to reduce, refine, or replace animal studies where unnecessary. Human cerebral organoids are three-dimensional cell aggregates that resemble the developing human brain functionally and structurally. Brain organoids may be valuable in investigating the replication, neuroinvasion, pathogenesis, virulence, and persistence of neurotropic viruses and provide scientific discernment when developing medical countermeasures destined for the human end-user.

Journal of VirologyVol. 99(11)
National Institutes of Health (US), German Center for Infection Research (DE), Division of Program Coordination Planning and Strategic Initiatives (US), Frederick National Laboratory for Cancer Research (US), National Institute of Allergy and Infectious Diseases (US), Bernhard Nocht Institute for Tropical Medicine (DE), Icahn School of Medicine at Mount Sinai (US)
Openalex Percentile: Top 58%
Virology and Viral Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.